Phenformin enhances the therapeutic benefit of BRAF <sup>V600E</sup> inhibition in melanoma
Ping Yuan(Anhui Medical University), Bin Zheng(Harvard University), Koichi Ito(Columbia University Irving Medical Center), Christina Guzzo(National Institutes of Health), Lewis C. Cantley(Harvard University), Marcus Bosenberg(Yale Cancer Center), Rolando Pérez‐Lorenzo(Autonomous University of Campeche), Martin McMahon(University of Utah), Jung‐Hyun Lee(University of Seoul), Che‐Hung Shen(Kaohsiung Medical University)
Cited by 223
Related Papers
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
Genomic Classification of Cutaneous Melanoma
|Cell|2015|3.3k
Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells
|Cell|2008|2.6k